BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Overview Fund Activity
Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

26 hedge funds and large institutions have $9.23M invested in BRAINSTORM CELL THERAPUTC in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
5
Closed
6
Calls
$253K
Puts
–
Net Calls
+$253K
Net Calls Change
-$74K

Top Buyers

1
SFM
1
Sphera Funds Management
Israel
$2.76M
2
PA
2
Perceptive Advisors
New York
$1.66M
3
JPMPWA
3
J.P. Morgan Private Wealth Advisors
California
$471K
4
TC
4
TFS Capital
Pennsylvania
$87K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.73M

Top Sellers

1
SM
1
Sabby Management
Florida
$70K
2
VKH
2
Virtu KCG Holdings
New York
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
GCA
4
Guardian Capital Advisors
Ontario, Canada
$0
5
UBS Group
5
UBS Group
Switzerland
$9K
Name Holding Trade Value Shares
Change 		Shares
Change %
VKH
26
Virtu KCG Holdings
New York
– -$177K -2,769 Closed
Citadel Advisors
27
Citadel Advisors
Florida
– -$74K -1,158 Closed
GCA
28
Guardian Capital Advisors
Ontario, Canada
– -$41K -667 Closed
TDC
29
Thompson Davis & Co
Virginia
– -$6K -100 Closed
DOA
30
D'Orazio & Associates
Virginia
– -$4K -67 Closed
ASN
31
Advisory Services Network
Georgia
– -$3K -44 Closed
1
2